Matrix Metalloproteinase-9 Expression by Hodgkin-Reed-Sternberg Cells Is Associated with Reduced Overall Survival in Young Adult Patients with Classical Hodgkin Lymphoma

被引：7

作者：

Campos, Antonio Hugo ^{[1
]}

Vassallo, Jose ^{[1
,2
]}

Soares, Fernando Augusto ^{[1
]}

机构：

[1] AC Camargo Canc Care Ctr, Dept Anat Pathol, Sao Paulo, Brazil

[2] Univ Estadual Campinas, Fac Med Sci, Lab Invest & Mol Pathol CIPED, Campinas, SP, Brazil

来源：

PLOS ONE | 2013年 / 8卷 / 09期

基金：

巴西圣保罗研究基金会;

关键词：

EPSTEIN-BARR-VIRUS; NITRIC-OXIDE SYNTHASES; MEMBRANE-PROTEIN; MATRIX METALLOPROTEINASES; DISEASE; CANCER; ICAM-1; ACTIVATION; INFECTION; PREDICTS;

D O I：

10.1371/journal.pone.0074793

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Previous studies have investigated the prognostic relevance of MMP9 in classical Hodgkin lymphoma (cHL), with negative results. However, we have found that MMP9 immunoistochemical expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in a subset of young adult Brazilian patients diagnosed with cHL. Additionally, we have observed that MMP9 expression by neoplastic cells in cHL is associated with EBV positivity. These results may support a rational basis for additional studies on the role of this metalloproteinase as a target for therapy in classical Hodgkin lymphoma.

引用

页数：6

共 33 条

[11] Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients [J].

Diepstra, Arjan ;

van Imhoff, Gustaaf W. ;

Schaapveld, Michael ;

Karim-Kos, Henrike ;

van den Berg, Anke ;

Vellenga, Edo ;

Poppema, Sibrand .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) :3815-3821

[12] G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences [J].

Faul, Franz ;

Erdfelder, Edgar ;

Lang, Albert-Georg ;

Buchner, Axel .

BEHAVIOR RESEARCH METHODS, 2007, 39 (02) :175-191

[13] Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity [J].

Fiore, E ;

Fusco, C ;

Romero, P ;

Stamenkovic, I .

ONCOGENE, 2002, 21 (34) :5213-5223

[14] Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status [J].

Flavell, JR ;

Baumforth, KRN ;

Williams, DM ;

Lukesova, M ;

Madarova, J ;

Noskova, V ;

Prochazkova, J ;

Lowe, D ;

Kolar, Z ;

Murray, PG ;

Nelson, PN .

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (03) :145-149

[15] Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting [J].

Gialeli, Chrisostomi ;

Theocharis, Achilleas D. ;

Karamanos, Nikos K. .

FEBS JOURNAL, 2011, 278 (01) :16-27

[16]

Gulley ML, 2002, AM J CLIN PATHOL, V117, P259

[17] A prognostic score for advanced Hodgkin's disease [J].

Hasenclever, D ;

Diehl, V .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1506-1514

[18] Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: A population-based study [J].

Keegan, THM ;

Glaser, SL ;

Clarke, CA ;

Gulley, ML ;

Craig, FE ;

DiGiuseppe, JA ;

Dorfman, RF ;

Mann, RB ;

Ambinder, RF .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7604-7613

[19] Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma [J].

Kuittinen, O ;

Soini, Y ;

Turpeenniemi-Hujanen, T .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (04) :205-212

[20] Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances [J].

Raffo, D. ;

Pontiggia, O. ;

Simian, M. .

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (11) :1937-1947

← 1 2 3 4 →